Aralez Pharm Inc (ARLZQ)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2017 | 12-2016 | 12-2015 | 12-2014 | 12-2013 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 28,892 | 64,943 | 24,816 | 40,582 | 32,828 |
| Marketable Securities | N/A | N/A | N/A | 2,679 | N/A |
| Receivables | 13,453 | 20,405 | 5,966 | 5,629 | 1,673 |
| Inventories | 6,643 | 4,548 | N/A | N/A | N/A |
| TOTAL | $52,675 | $92,331 | $32,007 | $49,474 | $35,295 |
| Non-Current Assets | |||||
| PPE Net | 7,453 | 7,316 | 251 | 27 | 39 |
| Intangibles | 392,127 | 416,888 | 0 | 0 | 0 |
| Other Non-Current Assets | 1,222 | 842 | 0 | 953 | 0 |
| TOTAL | $400,802 | $425,046 | $251 | $980 | $39 |
| Total Assets | $453,477 | $517,377 | $32,258 | $50,454 | $35,334 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 23,631 | 8,833 | 4,557 | 607 | 1,501 |
| Accrued Expenses | 28,496 | 32,141 | 11,932 | 2,153 | 4,788 |
| Other current liabilities | 15,733 | 16,300 | 0 | N/A | N/A |
| TOTAL | $67,860 | $57,274 | $16,489 | $3,713 | $17,546 |
| Non-Current Liabilities | |||||
| Long Term Debt | 274,546 | 274,441 | 0 | N/A | N/A |
| Deferred Revenues | N/A | N/A | N/A | N/A | 11,257 |
| Other Non-Current Liabilities | 92,055 | 62,903 | 986 | 0 | 0 |
| TOTAL | $370,398 | $340,617 | $986 | $N/A | $N/A |
| Total Liabilities | $438,258 | $397,891 | $17,475 | $3,713 | $17,546 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 67,011 | 65,684 | 63,910 | 32,246 | 30,761 |
| Common Shares | N/A | N/A | 33 | 32 | 31 |
| Retained earnings | -362,871 | -237,666 | -134,688 | -96,904 | -116,579 |
| Other shareholders' equity | 14,298 | 4,816 | 0 | 0 | 0 |
| TOTAL | $15,219 | $119,486 | $14,783 | $46,741 | $17,789 |
| Total Liabilities And Equity | $453,477 | $517,377 | $32,258 | $50,454 | $35,334 |